Medical Information
United Kingdom
 

This site is intended for UK healthcare professionals and the information provided is not intended as medical advice.

Responsibility for patient care resides with the healthcare professional.

This content is intended for UK healthcare professionals. Would you like to proceed?

I am a UK Healthcare ProfessionalYes, I am a healthcare professional
SelectI am a UK Healthcare ProfessionalYes, I am a healthcare professional
I am a UK Patient or Member of the General PublicNo, go back to the patient portal
SelectI am a UK Patient or Member of the General PublicNo, go back to the patient portal
Enter question keywords

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our online responses are currently unavailable, we apologise for the inconvenience this may cause. In the meantime, please use our web form to submit your medical enquiry. We respond to 90% of enquiries within 3 days.Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal review and is updated regularly to reflect new information.

This medicinal product has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency. It does not have a marketing authorisation, but this temporary authorisation grants permission for the medicine to be used for active immunization to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 12 years of age and over.

As with any new medicine in the UK, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

COVID-19 mRNA Vaccine BNT162b2

Enter question keywords

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our online responses are currently unavailable, we apologise for the inconvenience this may cause. In the meantime, please use our web form to submit your medical enquiry. We respond to 90% of enquiries within 3 days.Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal review and is updated regularly to reflect new information.

COVID-19 mRNA Vaccine BNT162b2 Quick Finder

Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Chat Online

Chat online with Pfizer Medical Information regarding your enquiry on the COVID-19 mRNA Vaccine BNT162b2. Please select COVID-19 mRNA Vaccine BNT162b2 on the first menu.

Medical Enquiry

Submit your medical enquiry on a Pfizer medicine

Call 01304 616161*
*Speak live with a Pfizer Medical Information professional regarding your medical enquiry from Monday to Friday between 09:00 AM and 17:00 PM (excluding holidays).
Report Adverse Event
Drug Safety Unit
If you are concerned about an adverse event, it should be reported on a Yellow Card.
Reporting forms and information can be found at https://coronavirus-yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store and include the vaccine brand and batch/Lot number if available.
Alternatively, adverse events of concern in association with Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 can be reported to Pfizer Medical Information on 01304 616161 or via www.pfizersafetyreporting.com
Please do not report the same adverse event(s) to both systems as all reports will be shared between Pfizer and MHRA (in an anonymised form) and dual reporting will create unnecessary duplicates.